{"transactions":[{"id":3391036,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":154363,"kind":"person","name":"Frueh Klaus","position":1,"cik":"0001786308","reported_name":"Frueh Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-2 Convertible Preferred Stock","published_at":"2019-10-18T23:50:47.000Z","date":"2019-10-16","kind":"exercise","acquired":false,"shares":218400,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A-2 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A-2 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A-2 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A-2 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in the name of the Klaus and Renate Frueh Revocable Trust Dated June 26, 2017."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":218400},"source":{"system":"sec-edgar","filing":"0001209191-19-053661","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919119053661/doc4.xml","form_type":"4"}},{"id":3391035,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":154363,"kind":"person","name":"Frueh Klaus","position":1,"cik":"0001786308","reported_name":"Frueh Klaus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-18T23:50:47.000Z","date":"2019-10-16","kind":"exercise","acquired":true,"shares":218400,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A-2 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in the name of the Klaus and Renate Frueh Revocable Trust Dated June 26, 2017."}],"balance_after":362844,"source":{"system":"sec-edgar","filing":"0001209191-19-053661","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919119053661/doc4.xml","form_type":"4"}}]}